EDUCATION AND TRAINING
Cardiology Fellowship, Emory University, Atlanta, GA, 1989–1992.
Fellowship, Medical Staff Fellow, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, MD, 1985–1989.
Medical Residency, George Washington University, Washington, DC, 1982–1985.
M.D., Baylor College of Medicine Houston, TX, 1981.
B.A., Brandeis University Waltham, MA, 1977.
Marshall A. Corson M.D., F.A.C.C., F.A.H.A.
Associate Professor of Medicine
Head, Section of Cardiology and Attending Physician, Harborview Medical Center
OFFICE ADDRESS:
Harborview Medical Center
325 Ninth Avenue
Box 359748
Seattle, WA 98104-2499
Clinic Appointments: (206) 744-3475
Phone: (206) 744-5853
Fax: (206) 744-2224
Email: mcorson@u.washington.edu
BOARD CERTIFICATION
American Board of Internal Medicine, Cardiovascular Diseases, 1993.
American Board of Internal Medicine, 1986.
AREAS OF CLINICAL EXPERTISE
Cardiovascular risk modification
General cardiology and cardiac catheterization
CURRENT RESEARCH INTERESTS
Use of biomarkers in prediction of cardiovascular risk
Clinical trials of novel treatments or treatment strategies for cardiovascular diseases
RECENT PUBLICATIONS
Davidson MH, Corson MA, Alberts MJ, Anderson JL, Gorelick PB, Jones PH, Lerman A, McConnell JP, Weintraub HS. Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines. Am J Cardiol 2008 Jun 16;101(12A):51F-57F. Review.
Crandall MA, Corson MA. Use of biomarkers to develop treatment strategies for atherosclerosis. Curr Treat Options Cardiovasc Med 2008 Aug;10(4):304-15.
Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 Jun 12;358(24):2545-59.
